Progress on Applying Carbon Dots for Inhibition of RNA Virus Infection

Nanotheranostics. 2022 Aug 21;6(4):436-450. doi: 10.7150/ntno.73918. eCollection 2022.

Abstract

Viral infection is a globally leading health issue. Annually, new lethal RNA viruses unexpectedly emerged and mutated threatening health and safety. Meanwhile, it is urgent to explore novel antiviral agents, which, however, takes years to be clinically available. Nonetheless, the development of carbon dots (CDs) in the past 20 years has exhibited their vast application potentials and revealed their promising capacity as future antiviral agents considering their versatile properties and significant antiviral responses. Thus, CDs have been widely investigated as an alternative of traditional chemotherapy for inhibiting viral infection and replication in vitro. Meanwhile, attempts to apply CDs to in vivo systems are in high demand. In this review, recent developments of CDs-based antiviral therapies are systematically summarized. Furthermore, the role of CDs in photodynamic inactivation to kill viruses or bacteria is briefly discussed.

Keywords: RNA virus; antiviral therapy; carbon dots; nanomedicine; virus infection treatment.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • Carbon / pharmacology
  • Humans
  • Quantum Dots*
  • RNA Virus Infections*
  • Virus Diseases*

Substances

  • Antiviral Agents
  • Carbon